Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →

KUH P30 Resource Core Center (P30 Clinical Trial Not Allowed)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is issuing a forecast for applications to establish Resource Core Centers under the P30 mechanism focused on kidney, urology, and hematology diseases. These centers are intended to serve as national hubs for the distribution of unique research resources such as data sets, biological reagents, experimental models, specialized tools, and expert services to the broader scientific community. The goal is to accelerate research progress by promoting open access and collaboration across institutions. Importantly, clinical trials are not permitted under this funding opportunity. Applicants must demonstrate the capacity to provide high-quality, sustainable, and widely accessible resources that align with the mission of advancing KUH-related research. These Resource Core Centers are required to coordinate closely with a separate Center Coordinating Hub funded under the U24 mechanism to form an integrated national network. This collaboration ensures standardized operations, efficient resource sharing, and unified communication across all participating centers. The solicitation is open to eligible institutions and does not specify any set-aside preferences or NAICS codes. Proposals must be submitted in response to the official notice, with the posting date listed as July 1, 2026. All inquiries should be directed to the designated point of contact, NIDDK_KUH@nih.gov, and further details can be found through the provided grants.gov link.

General Info

NIH forecasts P30 grants for national kidney, urology, hematology resource centers, excluding clinical trials.

Agency

Department Of Health And Human Services → National Institutes Of HealthView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health
View Agency Profile
Office AddressUS

Full Description

Show more

This Notice of Funding Opportunity (NOFO) requests applications for Resource Core Centers within the mission of NIDDK/Kidney, Urology, and Hematology (KUH) Diseases. Each Center is designed to advance national research efforts by sharing unique research resources (e.g., data, reagents, models, tools, services, expertise) with the broader community. The Resource Core Centers are expected to work collaboratively with a Center Coordinating Hub (U24) to form a national network.

Similar Contracts

NAICS: 541714
New
Federal
Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA3The RAPIID program, specifically Task Area 3, aims to bridge the gap between lab-scale breakthroughs in shelf-stable blood analogs and real-world deployment by advancing the regulatory approval, manufacturing scalability, and field usability of components originally developed under the FSHARP program. These components, designed to replicate the critical functions of whole blood—oxygen delivery, hemostasis, and volume expansion—now require rigorous clinical validation to demonstrate safety and efficacy when used in combination, as well as scalable production processes to ensure consistent, high-volume output. Efforts under this solicitation will focus on pushing these technologies through the regulatory pathway to secure necessary approvals for military and civilian use in austere, pre-hospital environments. The initiative seeks to develop and scale enabling fielding technologies that support the deployment, storage, and administration of these blood analogs outside controlled laboratory settings. This includes not only the components themselves but also the logistical and operational frameworks needed to integrate them into frontline medical workflows. Proposals must address the full spectrum of challenges—from manufacturing robustness and regulatory compliance to usability in extreme conditions—while aligning with the program’s goal of delivering a complete, authorized system capable of saving lives where traditional blood supplies are unavailable. The solicitation, issued by DARPA’s Biological Technologies Office, has a response deadline of July 29, 2026, and is open to all qualified entities, targeting the NAICS code 541714 for research and development in physical, engineering, and life sciences.
Defense Advanced Research Projects Agcy

POSTED

1 day ago

DEADLINE

in 26 days
View Details
NAICS: 541714
New
Grant
NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional)The National Institutes of Health, through the National Institute of Diabetes and Digestive and Kidney Diseases, is inviting applications for Disease Research and Translational Core Centers under the P30 mechanism, which is clinical trial optional. These centers aim to strengthen existing research institutions with established programs in cystic fibrosis, diabetes, nutrition, obesity, liver, and digestive diseases by fostering multidisciplinary collaboration, improving research rigor and reproducibility, and enhancing cost efficiency. The centers are structured around shared core services that provide access to specialized equipment, technical resources, analytical support, and expert-led training, all tailored to the specific needs of the research community within the institution. They also include a Pilot and Feasibility Grant Program to support new projects and a Scientific Catalyst Program administered through the Administrative Core, which promotes team building, mentoring, workshops, seminars, and visits by expert scientists to stimulate innovation and attract new investigators to the field. The program places strong emphasis on creating a nurturing environment for trainees and early-stage investigators, ensuring that emerging researchers benefit from mentorship and integrated scientific networks. Core services must be operated or overseen by recognized experts and are designed to be shared across center members to maximize impact and efficiency. The Scientific Catalyst Program specifically supports activities that build research capacity, encourage cross-disciplinary partnerships, and align scientific efforts with the center’s focus on chronic diseases. Applications are expected to demonstrate how the proposed infrastructure will enhance existing strengths and expand the institute’s research trajectory. The funding opportunity was posted on July 2, 2026, and inquiries should be directed to the designated NIDDK contact for further details.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Bioinformatics and Genomics support services - Navy Medical Research CommandThe U.S. Navy Medical Research Command at Fort Detrick, Maryland, is seeking high-quality bioinformatics and genomics support services to advance its scientific and operational missions. This solicitation, identified by number 20260000382, was posted on July 1, 2026, with responses due by July 7, 2026, and falls under NAICS code 541714 for research and development in biotechnology. The work will involve delivering advanced analytical capabilities in genomic data interpretation, computational biology, and related bioinformatics technologies tailored to the needs of military medical research. The performance location is Frederick, Maryland, where the NMRC operates, and the services are expected to directly support public health, infectious disease surveillance, and personnel readiness initiatives under the Department of Defense. The contracting activity is managed by the Naval Supply Systems Command Fleet Logistics Center in Norfolk, Virginia, with Austin Waller, Contracting Specialist, serving as the primary point of contact. There is no set-aside designation for small businesses or other categories, making this opportunity open to all qualified vendors. Respondents are directed to review the attached Request for Information and Performance Work Statement for detailed scope requirements, technical expectations, and submission guidelines. All proposals must be submitted through the SAM.gov portal prior to the deadline to be considered.
Navsup Flt Logistics Ctr Norfolk

POSTED

2 days ago

DEADLINE

in 4 days
View Details